News Briefing channel feed – Endpoints News

News Briefing channel feed

New Jersey biotech plans for tiny IPO; Vir gets $10M Gates Foundation grant for HIV vaccine

3 years ago

Bristol Myers gets priority review for first-line Reblozyl; Two startups clinch new cash

3 years ago

Janssen gets priority review for prostate cancer combo; ImmunoGen reports Q1 Elahere sales

3 years ago

4DMT unveils dose exploration data in wet AMD; Exicure installs new C-suite exec

3 years ago

Astellas and Twist team up in antibodies; FDA asks DBV for an additional safety study in peanut allergy patch

3 years ago

Gamida Cell looks to get $22M+ on its public offering launch; Esperion signs co-promotion pact with Currax

3 years ago

Otsuka subsidiary gets date with FDA for Lonsurf combo; Vaxcyte sells stock to bankroll PhIII vaccine trial

3 years ago

Smart Immune picks up $5M from Gates Foundation; Oxford Nanopore teams up with French diagnostics player

3 years ago

FDA asks Soligenix for new study after RTF; Navidea sells imaging agent for Alzheimer's

3 years ago

Treg player GentiBio turns to layoffs; Century Therapeutics CEO departs

3 years ago

Bavarian Nordic gathers patients for PhIII RSV trial; Adaptimmune handed $37M+ as GSK partnership ends

3 years ago

Horizon touts PhIV win for Tepezza; FDA sets adcomm dates for Sarepta, Pfizer, Eisai apps

3 years ago

ADC biotech brings total Series A raise to $89M+; Takeda hands $40M milestone to Arrowhead

3 years ago

Vertex and CRISPR send exa-cel for FDA approval; Aridis Therapeutics axes 20% of its workforce

3 years ago

GreenLight receives buyout offer; Apollomics completes SPAC merger

3 years ago

FDA grants full approval to Keytruda in tumor-agnostic setting; Candel pauses trial enrollment

3 years ago

Monopar puts a stop to its chemo complication drug; Exicure explores future transactions

3 years ago

89bio to net $275M from stock offering; Assembly Bio to pause work on one HBV inhibitor program

3 years ago

Ipsen receives new palovarotene PDUFA date; Acer halts development of ex-Sanofi drug

3 years ago

Immunome stops Covid-19 work; Hookipa drops CMV vaccine

3 years ago

LadRx starts hunt for new life; Statera lines up merger with diagnostics company

3 years ago

CRISPR hires William Blair analyst as new finance chief; Tiny EU biotech raises $20M+

3 years ago

Immunotherapy biotech unstealths with $13M; Anti-infection candidate for CF passes safety trial

3 years ago

Allorion raises $50M Series B; AskBio gets a new CEO

3 years ago

First page Previous page 17 18 192021 22 23 Next page Last page